Ranexa

DRUG2 trials

Sponsors

Midwest Cardiovascular Research Foundation, Gilead Sciences

Conditions

CardiomyopathyChest PainDyspneaSevere Renal Impairment

Phase 1

A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine

TerminatedNCT01675973

Gilead SciencesSevere Renal Impairment

Start: 2012-07-31End: 2012-08-31Updated: 2012-12-06

Phase 4

Ranolazine in Ischemic Cardiomyopathy

CompletedNCT01345188

Midwest Cardiovascular Research FoundationCardiomyopathy, Chest Pain, Dyspnea

Start: 2011-04-30End: 2014-04-30Updated: 2024-12-09